Search research articles
Contact Us
Filters
Showing results (61-70 of 268) with videos related to
Page
of 27
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1992
The impact of pharmacokinetically guided dose escalation strategies in phase I clinical trials: critical evaluation and recommendations for future studies
M A Graham, P Workman
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Pharmacokinetics and cancer chemotherapy
P Workman, M A Graham
Biochemical Pharmacology
|
June 1, 1990
Enzymology of the reductive bioactivation of SR 4233. A novel benzotriazine di-N-oxide hypoxic cell cytotoxin
M I Walton, P Workman
Biochemical Pharmacology
|
January 15, 1986
Estimating the kinetic parameters for enzymatic drug metabolism in the whole animal
J V Watson, P Workman
British Journal of Cancer
|
February 1, 1983
An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole
P R Twentyman, P Workman
British Journal of Cancer
|
February 1, 1980
Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs
R A White, P Workman
Journal of Chromatography
|
September 9, 1988
High-performance liquid chromatographic assay for the benzotriazine di-N-oxide (SR 4233) and its reduced metabolites in biological materials
M I Walton, P Workman
British Journal of Cancer
|
May 1, 1983
Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice
F Y Lee, P Workman
British Journal of Cancer
|
July 1, 1983
Chemosensitization by lipophilic nitroimidazoles
P R Twentyman, P Workman
Cancer Chemotherapy and Pharmacology
|
January 1, 1981
Structure-pharmacokinetic relationships for misonidazole analogues in mice
P Workman, J M Brown
Page
of 27
Search research articles
Search
Showing results (61-70 of 268) with videos related to
Sort By:
Page
of 27
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1992
The impact of pharmacokinetically guided dose escalation strategies in phase I clinical trials: critical evaluation and recommendations for future studies
M A Graham, P Workman
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Pharmacokinetics and cancer chemotherapy
P Workman, M A Graham
Biochemical Pharmacology
|
June 1, 1990
Enzymology of the reductive bioactivation of SR 4233. A novel benzotriazine di-N-oxide hypoxic cell cytotoxin
M I Walton, P Workman
Biochemical Pharmacology
|
January 15, 1986
Estimating the kinetic parameters for enzymatic drug metabolism in the whole animal
J V Watson, P Workman
British Journal of Cancer
|
February 1, 1983
An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole
P R Twentyman, P Workman
British Journal of Cancer
|
February 1, 1980
Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs
R A White, P Workman
Journal of Chromatography
|
September 9, 1988
High-performance liquid chromatographic assay for the benzotriazine di-N-oxide (SR 4233) and its reduced metabolites in biological materials
M I Walton, P Workman
British Journal of Cancer
|
May 1, 1983
Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice
F Y Lee, P Workman
British Journal of Cancer
|
July 1, 1983
Chemosensitization by lipophilic nitroimidazoles
P R Twentyman, P Workman
Cancer Chemotherapy and Pharmacology
|
January 1, 1981
Structure-pharmacokinetic relationships for misonidazole analogues in mice
P Workman, J M Brown
Page
of 27